TRP_1170x120_3-8-19

insulin lispro

Lilly to introduce lower-priced insulin

Lilly to introduce lower-priced insulin

INDIANAPOLIS — Reinforcing their commitment to lower out-of-pocket costs for people who need insulin, Eli Lilly and Co. announced it will introduce a lower-priced version of Humalog (insulin lispro injection 100 units/mL) in the United States — providing people with diabetes an insulin option that will have a list price 50 percent lower than the current

Sanofi cleared to market Admelog mealtime insulin

Sanofi cleared to market Admelog mealtime insulin

PARIS — Sanofi has received Food and Drug Administration approval for Admelog, described as the first follow-on insulin lispro to help people with diabetes manage blood sugar levels at mealtime. Sanofi said Monday that Admelog (insulin lispro injection, 100 units/ml) will be available in both vials and the SoloStar pen, which is the most-used disposable